BioPharmaTrend
Latest News
All Topics
  • Artificial Intelligence
  • NeuroTech
  • Premium Content
  • Knowledge Center
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Subscribe
Login/Join
back to Directory

Ginkgo Bioworks

Ginkgo Bioworks logo

Website
http://ginkgobioworks.com/
Founded
2009
Patents
15
Publications
68

Ginkgo Bioworks designs, engineers, develops, tests, and licenses organisms. It discovers molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals.

Gingko Bioworks also provides probiotic bacteria to protect the body from dangerous infections, and it generates libraries of molecules. It serves cultured ingredients, carbon mitigation, probiotics, and natural product discovery markets.

Tom Knight, Reshama Shetty, Jason Kelly, Barry Canton, and Austin Che founded Ginkgo Bioworks in 2009. Its headquarters in Boston in Massachusetts.

Interviews

Cracking the Code of Life: An Interview with Stef van Grieken, CEO of Cradle, on AI-Driven Protein Engineering

Posts Mentioning This Company

19 Companies Pioneering AI Foundation Models in Pharma and Biotech

June 19, 2024  
Foundation models represent a new paradigm in artificial intelligence (AI), revolutionizing how machine learning models are developed and deployed. As these models grow increasingly capable, they become useful for applications across a wide range of economic functions and industries, including biotech. Foundation models are a class of large-scale machine learning …

The Growing Momentum for AI Foundation Models in Biotech and 12 Notable Companies

March 17, 2024  
As artificial intelligence (AI) foundation models grow increasingly capable, they become useful for applications across a wide range of economic functions and industries, including biotech. The most prominent examples of general purpose foundation models are the GPT-3 and GPT-4 models, which form the basis of ChatGPT, and BERT, or Bidirectional …
AI in Synthetic Biology: From Gene Editing to Pathway Design

From Gene Editing to Pathway Design: How AI is Transforming Synthetic Biology

Oct. 20, 2023  
It is hard to overestimate the potential of biotechnology to address some of the most pressing challenges of the 21st century. These challenges include feeding a growing global population, improving healthcare and access to therapies, and mitigating the impacts of climate change.
#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials

 

News

  • 2024-02-28
    A Busy Day for Ginkgo Bioworks

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
gnews  Google News
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Premium Content
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Membership
  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.